Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith B Manola

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 17, 2011
When bad things happen to good studiesJudith B Manola, Robert J Gray
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 22, 2013
Vandetanib plus chemotherapy for induction followed by vandetanib or placebo as maintenance for patients with advanced non-small-cell lung cancer: a randomized phase 2 PrECOG study (PrE0501)Joseph Aisner, Judith B Manola, Shaker R Dakhil, et al.
Clinical Prostate Cancer|July 29, 2004
Assessing a prostate cancer brachytherapy technique using early patient-reported symptoms: a potential early indicator for technology assessment?Pearl H Seo, Anthony V D'Amico, Jack A Clark, et al.
Clinical Prostate Cancer|July 29, 2004
Plasma levels of heat shock protein 70 in patients with prostate cancer: a potential biomarker for prostate cancerMiyako Abe, Judith B Manola, William K Oh, et al.
AJR. American Journal of Roentgenology|November 22, 2007
CT and PET: early prognostic indicators of response to imatinib mesylate in patients with gastrointestinal stromal tumorClay H Holdsworth, Ramsey D Badawi, Judith B Manola, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 2, 2005
The telomerase reverse transcriptase regulates chromatin state and DNA damage responsesKenkichi Masutomi, Richard Possemato, Judy M Y Wong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2015
BEST: A Randomized Phase II Study of Vascular Endothelial Growth Factor, RAF Kinase, and Mammalian Target of Rapamycin Combination Targeted Therapy With Bevacizumab, Sorafenib, and Temsirolimus in Advanced Renal Cell Carcinoma--A Trial of the ECOG-ACRIN Cancer Research Group (E2804)Keith T Flaherty, Judith B Manola, Michael Pins, et al.
European Radiology|October 14, 2004
Liposarcoma subtypes: identification with computed tomography and ultrasound-guided percutaneous needle biopsyPaul Nikolaidis, Stuart G Silverman, Edmund S Cibas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2012
Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancerMichael J Fisch, Ju-Whei Lee, Matthias Weiss, et al.
Clinical Genitourinary Cancer|December 3, 2014
A phase I study of everolimus and docetaxel in patients with castration-resistant prostate cancerKevin D Courtney, Judith B Manola, Aymen A Elfiky, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 17, 2011
When bad things happen to good studiesJudith B Manola, Robert J Gray
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 22, 2013
Vandetanib plus chemotherapy for induction followed by vandetanib or placebo as maintenance for patients with advanced non-small-cell lung cancer: a randomized phase 2 PrECOG study (PrE0501)Joseph Aisner, Judith B Manola, Shaker R Dakhil, et al.
Clinical Prostate Cancer|July 29, 2004
Assessing a prostate cancer brachytherapy technique using early patient-reported symptoms: a potential early indicator for technology assessment?Pearl H Seo, Anthony V D'Amico, Jack A Clark, et al.
Clinical Prostate Cancer|July 29, 2004
Plasma levels of heat shock protein 70 in patients with prostate cancer: a potential biomarker for prostate cancerMiyako Abe, Judith B Manola, William K Oh, et al.
AJR. American Journal of Roentgenology|November 22, 2007
CT and PET: early prognostic indicators of response to imatinib mesylate in patients with gastrointestinal stromal tumorClay H Holdsworth, Ramsey D Badawi, Judith B Manola, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 2, 2005
The telomerase reverse transcriptase regulates chromatin state and DNA damage responsesKenkichi Masutomi, Richard Possemato, Judy M Y Wong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2015
BEST: A Randomized Phase II Study of Vascular Endothelial Growth Factor, RAF Kinase, and Mammalian Target of Rapamycin Combination Targeted Therapy With Bevacizumab, Sorafenib, and Temsirolimus in Advanced Renal Cell Carcinoma--A Trial of the ECOG-ACRIN Cancer Research Group (E2804)Keith T Flaherty, Judith B Manola, Michael Pins, et al.
European Radiology|October 14, 2004
Liposarcoma subtypes: identification with computed tomography and ultrasound-guided percutaneous needle biopsyPaul Nikolaidis, Stuart G Silverman, Edmund S Cibas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2012
Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancerMichael J Fisch, Ju-Whei Lee, Matthias Weiss, et al.
Clinical Genitourinary Cancer|December 3, 2014
A phase I study of everolimus and docetaxel in patients with castration-resistant prostate cancerKevin D Courtney, Judith B Manola, Aymen A Elfiky, et al.
Pageof 2